Inflammatix raised $57M in Series E funding led by Khosla Ventures and Think.Health to support the commercialization of the TriVerity™ Test.
Amount Raised
$57 Million
Round Type
Series E
SunnyvaleBiotechnologyInvestors
Description
Inflammatix has secured $57 million in Series E financing, which will aid in the regulatory filing and early commercialization of its TriVerity™ Acute Infection and Sepsis Test. The funding will also facilitate the expansion of the company’s commercial team.
Quick answer
Inflammatix raised $57 Million in a Series E round, dated September 12, 2024. Investors: Think.Health and Khosla Ventures. Inflammatix is based in Sunnyvale, California, United States.
- How much did Inflammatix raise?
- Inflammatix raised $57 Million in a Series E round on September 12, 2024.
- Who invested in Inflammatix?
- Think.Health and Khosla Ventures are named as investors in this round.
- What does Inflammatix do?
- Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response..
- Where is Inflammatix based and how big is it?
- Inflammatix is based in Sunnyvale, California, United States. Fundz records about 87 employees.
- Who are the decision-makers at Inflammatix?
- Fundz holds 1 contact at Inflammatix, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Inflammatix that raised within 45 days of this round, from Fundz verified event records.
- ONWARD Medical raised $54M (Post-IPO Equity) on October 26, 2024.
- Pharos raised $5M (Seed) on October 25, 2024.
- Agomab raised $89M (Series D) on October 25, 2024.
- MelliCell raised an undisclosed amount (Seed) on October 25, 2024.
- Epitopea raised $31M (Pre-Series A) on October 25, 2024.
- Revalia Bio raised $12M on October 25, 2024.
Who to call at Inflammatix, and when
A new round usually means Inflammatix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inflammatix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inflammatix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inflammatix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inflammatix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inflammatix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.